Fig. 2From: Association between sex and outcomes in patients with non-small-cell lung cancer receiving combination chemoimmunotherapy as a first-line therapy: a systematic review and meta-analysis of randomized clinical trialsForest plots of hazard ratios according to the patients’ sex. (a) OS in female patients. (b) OS in male patients. (c) PFS in female patients. (d) PFS in male patients. CI, confidence interval; Con., control arm; Exp., experimental arm; HR, hazard ratio; OS, overall survival; PFS, progression-free survivalBack to article page